| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |